Posted On: 08/15/2016 11:58:10 AM
Post# of 8675

$ARTH Arch Therapeutics Reports AC5 Topical Hemostatic Device Meets Primary and Secondary Endpoints in First Clinical Study
http://finance.yahoo.com/news/arch-therapeuti...00951.html
http://finance.yahoo.com/news/arch-therapeuti...00951.html

